Hyperfine (Hyperfine) Debt-to-Equity : 0.00 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hyperfine Debt-to-Equity?

Hyperfine's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.19 Mil. Hyperfine's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Hyperfine's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $75.64 Mil. Hyperfine's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Hyperfine's Debt-to-Equity or its related term are showing as below:

HYPR's Debt-to-Equity is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 0.21
* Ranked among companies with meaningful Debt-to-Equity only.

Hyperfine Debt-to-Equity Historical Data

The historical data trend for Hyperfine's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyperfine Debt-to-Equity Chart

Hyperfine Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Hyperfine Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Hyperfine's Debt-to-Equity

For the Medical Devices subindustry, Hyperfine's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyperfine's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hyperfine's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Hyperfine's Debt-to-Equity falls into.

Hyperfine Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Hyperfine's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.185	+	0)	/	84.399
	=	0.00

Hyperfine's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.189	+	0)	/	75.638
	=	0.00

Hyperfine (NAS:HYPR) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Hyperfine Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Hyperfine's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyperfine (Hyperfine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hyperfine Inc (NAS:HYPR) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

351 New Whitfield Street, Guilford, CT, USA, 06437

Website

https://www.hyperfine.io

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. Legacy Hyperfine and Liminal represent two operating segments of the company. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Executives

Thomas Teisseyre	officer: Chief Operating Officer	C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Khan Siddiqui	officer: See Remarks	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Brett Hale	officer: Chief Administrative Officer	C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Maria Sainz	director	C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Jonathan M Rothberg	director, 10 percent owner	C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Alok Gupta	officer: Chief Financial Officer	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Neela Paykel	officer: Gen Counsel & Corp Secretary	530 OLD WHITFIELD STREET, GUILFORD CT 06437
David D Scott	director, officer: President and CEO	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Ruth A Fattori	director	1303 EAST ALGONQUIN ROAD, SCHAUMBURG IL 60196
Hc Sponsor Llc	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, 28TH FLOOR, NEW YORK NY 10001
Arthur Bruce Cohen	10 percent owner	12 SOUTH MAIN STREET, SUITE #203, NORWALK CT 06854
Healthcor Group, Llc	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
Joseph Patrick Healey	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
R Scott Huennekens	director	C/O VOLCANO CORPORATION, 11455 EL CAMINO REAL, SUITE 460, SAN DIEGO CA 92130
Scott A. White	officer: Chief Commercial Officer	530 OLD WHITFIELD STREET, GUILFORD CT 06437